Shu Hui Chen
Corporate Officer/Principal bei WUXI PHARMATECH (CAYMAN) INC. (ADR)
Profil
Derzeit ist Shu Hui Chen Vice President bei WuXi AppTec Co., Ltd. und Chief Scientific Officer von Wuxi PharmaTech (Cayman) Inc. In der Vergangenheit war er Research Advisor bei Eli Lilly & Co, Associate Director-Chemistry bei Vion Pharmaceuticals, Inc. und Senior Research Investigator bei Bristol-Myers Squibb Co. Dr. Chen erhielt einen Doktortitel von der Yale University und einen Bachelor-Abschluss von der Fudan University.
Aktive Positionen von Shu Hui Chen
Unternehmen | Position | Beginn |
---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Shu Hui Chen
Unternehmen | Position | Ende |
---|---|---|
WUXI APPTEC CO., LTD. | Chief Tech/Sci/R&D Officer | 23.03.2016 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2004 |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01.01.1997 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1995 |
Ausbildung von Shu Hui Chen
Yale University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |